Stories

Novartis has been at the forefront of advances in how blood cancers and serious blood disorders are treated, helping patients live their best lives.

Inspired by Emily Whitehead, along with other early patients treated with CAR-T cell therapy, Novartis embarked on a pioneering journey to reimagine cancer treatment. After 10 years, we continue to relentlessly pursue new science around cell and gene therapies to transform the lives of patients today and in the future.

Novartis is collaborating with Microsoft to apply machine learning to medicinal chemistry — part of an effort to leverage AI to bring treatments to patients more efficiently.

Inside the hunt for new antivirals to combat the current pandemic and to prepare for future ones.

From an eccentric idea to a revolution in medicine – the history of immunotherapy and a peek into its future.

Novartis researchers aim to improve the lives of patients with osteoarthritis.

We’re working to bring the hope of advanced medicine to more patients.

Targeting inflammation to fight cancer is a new approach with a long history.

A new type of medicine that targets RNA was discovered by accident and could change the way some diseases are treated.

Novartis researchers aim to preserve kidney function – and quality of life – for patients.

Novartis researchers are using data to accelerate drug development.